Drugmaker Takes FDA Generics Rule Fight To DC Circ.
Biotechnology company ViroPharma Inc. argued in a brief to the D.C. Circuit on Thursday that it has standing to sue the U.S. Food and Drug Administration over changes to generic-drug testing...To view the full article, register now.
Already a subscriber? Click here to view full article